BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37200049)

  • 1. Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition.
    Zheng RR; Zhao LP; Huang CY; Cheng H; Yang N; Chen ZX; Cai H; Zhang W; Kong RJ; Li SY
    ACS Nano; 2023 Jun; 17(11):9972-9986. PubMed ID: 37200049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmon-Driven Catalytic Chemotherapy Augments Cancer Immunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Ding Y; Sun Z; Gao Y; Zhang S; Yang C; Qian Z; Jin L; Zhang J; Zeng C; Mao Z; Wang W
    Adv Mater; 2021 Aug; 33(34):e2102188. PubMed ID: 34278622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
    Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cascade Immune Activation of Self-Delivery Biomedicine for Photodynamic Immunotherapy Against Metastatic Tumor.
    Zheng RR; Zhao LP; Yang N; Chen ZX; Kong RJ; Huang CY; Rao XN; Chen X; Cheng H; Li SY
    Small; 2023 Jan; 19(3):e2205694. PubMed ID: 36366925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate.
    Lu Y; Xu F; Wang Y; Shi C; Sha Y; He G; Yao Q; Shao K; Sun W; Du J; Fan J; Peng X
    Biomaterials; 2021 Nov; 278():121167. PubMed ID: 34624752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-delivery oxidative stress amplifier for chemotherapy sensitized immunotherapy.
    Zhao L; Zheng R; Liu L; Chen X; Guan R; Yang N; Chen A; Yu X; Cheng H; Li S
    Biomaterials; 2021 Aug; 275():120970. PubMed ID: 34146889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway.
    Lu J; Liu X; Liao YP; Wang X; Ahmed A; Jiang W; Ji Y; Meng H; Nel AE
    ACS Nano; 2018 Nov; 12(11):11041-11061. PubMed ID: 30481959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclometalated iridium(III) complexes induce immunogenic cell death in HepG2 cells via paraptosis.
    Liao J; Zhang Y; Huang M; Liang Z; Gong Y; Liu B; Li Y; Chen J; Wu W; Huang Z; Sun J
    Bioorg Chem; 2023 Nov; 140():106837. PubMed ID: 37683535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
    Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IDO-inhibitor potentiated immunogenic chemotherapy abolishes primary tumor growth and eradicates metastatic lesions by targeting distinct compartments within tumor microenvironment.
    Li Q; Liu J; Fan H; Shi L; Deng Y; Zhao L; Xiang M; Xu Y; Jiang X; Wang G; Wang L; Wang Z
    Biomaterials; 2021 Feb; 269():120388. PubMed ID: 33172606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy.
    Zhou L; Zhang P; Wang H; Wang D; Li Y
    Acc Chem Res; 2020 Sep; 53(9):1761-1772. PubMed ID: 32819102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic Nanomedicine with Boronate Bonds for Augmented Chemo-Immunotherapy via Synergistic Modulation of Tumor Immune Microenvironment.
    Li Y; Wu Y; Fang Z; Zhang Y; Ding H; Ren L; Zhang L; Gong Q; Gu Z; Luo K
    Adv Mater; 2024 Jan; 36(2):e2307263. PubMed ID: 37743633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockage of the IDO1 pathway by charge-switchable nanoparticles amplifies immunogenic cell death for enhanced cancer immunotherapy.
    Shi M; Zhang J; Wang Y; Han Y; Zhao X; Hu H; Qiao M; Chen D
    Acta Biomater; 2022 Sep; 150():353-366. PubMed ID: 35843594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin-/NLG919 prodrugs-constructed liposomes for effective chemo-immunotherapy of colorectal cancer.
    Shen F; Feng L; Zhu Y; Tao D; Xu J; Peng R; Liu Z
    Biomaterials; 2020 Oct; 255():120190. PubMed ID: 32563943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria-associated ER stress evokes immunogenic cell death through the ROS-PERK-eIF2α pathway under PTT/CDT combined therapy.
    Feng X; Lin T; Chen D; Li Z; Yang Q; Tian H; Xiao Y; Lin M; Liang M; Guo W; Zhao P; Guo Z
    Acta Biomater; 2023 Apr; 160():211-224. PubMed ID: 36792045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Light-responsive hyaluronic acid nanomicelles co-loaded with an IDO inhibitor focus targeted photoimmunotherapy against "immune cold" cancer.
    Wu C; Xu J; Xie Z; Huang H; Li N; Wei X; Li T; Yang H; Li S; Qin X; Liu Y
    Biomater Sci; 2021 Nov; 9(23):8019-8031. PubMed ID: 34718362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy.
    Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H
    Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ photothermal nano-vaccine based on tumor cell membrane-coated black phosphorus-Au for photo-immunotherapy of metastatic breast tumors.
    Huang D; Wu T; Lan S; Liu C; Guo Z; Zhang W
    Biomaterials; 2022 Oct; 289():121808. PubMed ID: 36137415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptable peptide-based therapeutics modulating tumor microenvironment for combinatorial radio-immunotherapy.
    Li M; Wang Z; Liu X; Song N; Song Y; Shi X; Liu J; Liu J; Yu Z
    J Control Release; 2021 Dec; 340():35-47. PubMed ID: 34699869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-Near infrared dye conjugate induces immunogenic cell death to enhance cancer immunotherapy.
    Jin C; Wang Y; Li Y; Li J; Zhou S; Yu J; Wang Z; Yu Y; Zhang H; Wang D; He Z; Wang Y
    Int J Pharm; 2021 Sep; 607():121027. PubMed ID: 34418473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.